ArticleDermatologic therapy2020
How can I take care of you? The dermatologist meets patients' needs during the COVID-19 pandemic.
Article in Dermatologic therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions.Molecules (Basel, Switzerland) · 2023Review
- Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art.International journal of molecular sciences · 2023Review
- Latest combination therapies in psoriasis: Narrative review of the literature.Dermatologic therapy · 2022Review
- Biological Treatments for Pediatric Psoriasis: State of the Art and Future Perspectives.International journal of molecular sciences · 2022Review
- Vaccines Against SARS-CoV-2 in Psoriasis Patients on Immunosuppressive Therapy: Implications of Vaccination Nationwide Campaign on Clinical Practice in Italy.Dermatology and therapy · 2021Review
- Skin manifestations of COVID-19 in children: Part 3.Clinical and experimental dermatology · 2021Review
- Safety and Efficacy of Vaccines during COVID-19 Pandemic in Patients Treated with Biological Drugs in a Dermatological Setting.Healthcare (Basel, Switzerland) · 2021Review
- Hydroxychloroquine, dermatology, and SARS-CoV-2: Updating an old association.Journal of medical virology · 2021Article
- Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience.Dermatologic therapy · 2021Article
- Time to restart: protocol of resumption of activities of a dermatological clinic of a level II hospital in the COVID-19 era.International journal of dermatology · 2020Article
- Does COVID-19 influence sexual behaviors?Dermatologic therapy · 2020Article
- Active implications for dermatologists in 'SARS-CoV-2 ERA': Personal experience and review of literature.Journal of the European Academy of Dermatology and Venereology : JEADV · 2020Review
- Responsible Innovation in AI-Driven Teledentistry: Ethical, Legal, and Economic Considerations for the Globalization Era.Discoveries (Craiova, Romania)Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.